Target Name: RTL8C
NCBI ID: G8933
Other Name(s): RTL8C_HUMAN | MAR8C | MART8C | CAAX box 1 | Retrotransposon Gag-like protein 8C | mammalian retrotransposon-derived 8C | Retrotransposon Gag like 8C | retrotransposon Gag like 8C | FAM127A | Sushi-Ichi retrotransposon homolog 5 | Mammalian retrotransposon derived protein 8C | SIRH5 | CXX1 | mammalian retrotransposon derived protein 8C | Mart8 | family with sequence similarity 127 member A | retrotransposon Gag-like protein 8B | Mar8 | protein FAM127A

Exploring The Potential of RTL8C as A Drug Target Or Biomarker

RTL8C (Reverse Transcriptase-Like 8C) is a non-coding RNA molecule that has been found to be highly expressed in various tissues and cells, including the brain, heart, and gastrointestinal tract. Its functions and potential clinical applications continue to attract researchers' interest. In this article, we will explore the potential of RTL8C as a drug target or biomarker.

Potential Drug Target
RTL8C has been identified as a potential drug target due to its unique structure and its expressed levels in various tissues. It is a small RNA molecule that contains 229 amino acid residues and is characterized by a unique stem-loop structure. This structure is similar to that of reverse transcriptase, which is a key enzyme in the process of DNA replication. Therefore, it is speculated that RTL8C may have some degree of influence on gene expression.

RTL8C has been shown to play a role in various physiological processes, including cell growth, differentiation, and inflammation. Its expressed levels have also been linked to various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. This suggests that RTL8C may be a promising target for new drugs that can treat these diseases.

Biomarker Potential
RTL8C has also been identified as a potential biomarker for various diseases. Its expressed levels have been shown to be elevated in various diseases, including neurodegenerative diseases, cancer, and cardiovascular disease. This suggests that RTL8C may be a useful biomarker for these diseases and could be used in diagnostic tests.

RTL8C also has been shown to be involved in the regulation of various cellular processes, including cell growth, apoptosis, and inflammation. Its expressed levels have also been linked to various signaling pathways, including TGF-β and NF-kappa-B signaling pathways. This suggests that RTL8C may be involved in the regulation of cellular processes that are important for human health and may be a useful target for new drugs that can modulate these processes.

Conclusion
In conclusion, RTL8C is a non-coding RNA molecule that has been identified as a potential drug target and biomarker. Its unique structure and its expressed levels in various tissues make it a promising target for new drugs that can modulate its functions. Further research is needed to fully understand the role of RTL8C in various physiological processes and to develop new drugs that can target its unique properties.

Protein Name: Retrotransposon Gag Like 8C

More Common Targets

RTL9 | RTN1 | RTN2 | RTN3 | RTN4 | RTN4IP1 | RTN4R | RTN4RL1 | RTN4RL2 | RTP1 | RTP2 | RTP3 | RTP4 | RTP5 | RTRAF | RTTN | RUBCN | RUBCNL | RUFY1 | RUFY2 | RUFY3 | RUFY4 | RUNDC1 | RUNDC3A | RUNDC3A-AS1 | RUNDC3B | RUNX1 | RUNX1-IT1 | RUNX1T1 | RUNX2 | RUNX2-AS1 | RUNX3 | RUNX3-AS1 | RUSC1 | RUSC1-AS1 | RUSC2 | RUSF1 | RUVBL1 | RUVBL1-AS1 | RUVBL2 | RWDD1 | RWDD2A | RWDD2B | RWDD3 | RWDD3-DT | RWDD4 | RXFP1 | RXFP2 | RXFP3 | RXFP4 | RXRA | RXRB | RXRG | RXYLT1 | Ryanodine receptor | RYBP | RYK | RYR1 | RYR2 | RYR3 | RZZ complex | S100 Calcium Binding Protein | S100A1 | S100A10 | S100A11 | S100A11P1 | S100A12 | S100A13 | S100A14 | S100A16 | S100A2 | S100A3 | S100A4 | S100A5 | S100A6 | S100A7 | S100A7A | S100A7L2 | S100A7P1 | S100A8 | S100A9 | S100B | S100G | S100P | S100PBP | S100Z | S1PR1 | S1PR1-DT | S1PR2 | S1PR3 | S1PR4 | S1PR5 | SAA1 | SAA2 | SAA2-SAA4 | SAA3P | SAA4 | SAAL1 | SAC3D1 | SACM1L